Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goli Samimi

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial CancerBritt K Erickson, Howard Bailey, Rebecca C Arend, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceMark E Sherman, Ronny I Drapkin, Neil S Horowitz, et al.
Cancer Medicine|January 20, 2026
Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial CancerDib Sassine, Yongmei Huang, Chin Hur, et al.
Oncotarget|November 18, 2015
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerKim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.
Journal of the National Cancer Institute|June 13, 2025
Trends in uterine cancer incidence and mortality: insights from a natural history modelWilliam D Hazelton, Matthew Prest, Ling Chen, et al.
Translational Oncology|February 22, 2023
Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinomaOmali Pitiyarachchi, Yeh Chen Lee, Hao-Wen Sim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Obstetrics and Gynecology|February 5, 2026
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine CancerKevin J Rouse, William D Hazelton, Axel Frotscher, et al.
Cancer Cell|December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United StatesJason D Wright, Matthew T Prest, Jennifer S Ferris, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2025
Pilot Study of Daily Exemestane in Women with Endometrial Intraepithelial Neoplasia or Low-Grade Endometrial CancerBritt K Erickson, Howard Bailey, Rebecca C Arend, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 26, 2016
Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the EvidenceMark E Sherman, Ronny I Drapkin, Neil S Horowitz, et al.
Cancer Medicine|January 20, 2026
Neoadjuvant Chemotherapy Versus Primary Cytoreductive Surgery for Metastatic Endometrial CancerDib Sassine, Yongmei Huang, Chin Hur, et al.
Oncotarget|November 18, 2015
Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancerKim Moran-Jones, Brian S Gloss, Rajmohan Murali, et al.
Journal of the National Cancer Institute|June 13, 2025
Trends in uterine cancer incidence and mortality: insights from a natural history modelWilliam D Hazelton, Matthew Prest, Ling Chen, et al.
Translational Oncology|February 22, 2023
Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinomaOmali Pitiyarachchi, Yeh Chen Lee, Hao-Wen Sim, et al.
Cancer Prevention Research (Philadelphia, Pa.)|August 24, 2022
Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-OophorectomyMeghna S Trivedi, Nadir Arber, Eitan Friedman, et al.
Obstetrics and Gynecology|February 5, 2026
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine CancerKevin J Rouse, William D Hazelton, Axel Frotscher, et al.
Cancer Cell|December 8, 2009
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2Samuel C Mok, Tomas Bonome, Vinod Vathipadiekal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 1, 2025
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United StatesJason D Wright, Matthew T Prest, Jennifer S Ferris, et al.
Pageof 8